Stocktoria

CERUS CORP CERS

Nasdaq · stock · Surgical & Medical Instruments & Apparatus · website · IPO 1997-01-31 · LEI

CERUS CORP financials (annual)

Revenue
$39.3M $51.3M $76.1M $93.8M $114.2M $159.5M $188.3M $186.8M $201.3M $233.8M 2016201720182019202020212022202320242025
Net income
-$62.9M -$60.6M -$57.6M -$71.2M -$59.9M -$54.4M -$42.8M -$37.5M -$20.9M -$15.6M 2016201720182019202020212022202320242025
Free cash flow
-$54.1M -$52.6M -$32.4M -$74.4M -$43.4M -$34.8M -$27.6M -$47.8M $8.5M $1.1M 2016201720182019202020212022202320242025

Bars are annual figures from 2016 to 2025; red bars are negative (a loss or cash outflow).

MetricFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue$233.8M$201.3M$186.8M$188.3M$159.5M$114.2M$93.8M$76.1M$51.3M$39.3M
Gross profit$16.9M
SG&A expense$80.9M$75.9M$75.5M$83.3M$81.3M$67.0M$66.2M$56.8M$52.6M$49.0M
Operating income-$8.7M-$14.2M-$30.1M-$34.1M-$48.9M-$58.3M-$66.2M-$55.0M-$57.5M-$61.4M
Interest expense$8.4M$5.8M$4.9M$3.7M$6.1M$4.0M$3.0M$2.4M
Income tax$354,000$205,000$325,000$488,000$319,000$284,000$263,000$229,000$3.9M$175,000
Net income-$15.6M-$20.9M-$37.5M-$42.8M-$54.4M-$59.9M-$71.2M-$57.6M-$60.6M-$62.9M
EPS (diluted)$-0.08$-0.11$-0.21$-0.24$-0.32$-0.37$-0.44$-0.56$-0.62
Operating cash flow$4.8M$11.4M-$43.2M-$25.6M-$33.9M-$41.8M-$65.5M-$31.2M-$52.2M-$53.5M
Free cash flow$1.1M$8.5M-$47.8M-$27.6M-$34.8M-$43.4M-$74.4M-$32.4M-$52.6M-$54.1M
Cash & equivalents$20.0M$20.3M$11.6M$35.6M$48.8M$36.6M$35.0M$28.9M$13.7M$22.6M
Inventory$56.1M$38.1M$39.9M$29.0M$26.8M$23.3M$19.5M$13.5M$14.5M$12.5M
Total assets$221.9M$200.9M$197.7M$218.1M$237.5M$221.4M$165.5M$163.5M$98.2M$103.5M
Total liabilities$156.9M$144.0M$144.3M$149.5M$151.9M$117.6M$108.5M$78.9M$59.3M$45.7M
Shareholders' equity$65.0M$56.9M$53.4M$68.6M$85.6M$103.8M$57.1M$84.5M$38.9M$57.8M

Growth · year-over-year · Revenue CAGR 21.9%

MetricFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue growth+16.1%+7.8%-0.8%+18.1%+39.6%+21.8%+23.3%+48.2%+30.7%+14.8%
Free cash flow growth-87.0%

Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.